{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T17:25:34Z","timestamp":1790702734169,"version":"4.1.0"},"reference-count":74,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2017,4,22]],"date-time":"2017-04-22T00:00:00Z","timestamp":1492819200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Heart Fail Rev"],"published-print":{"date-parts":[[2017,5]]},"DOI":"10.1007\/s10741-017-9615-6","type":"journal-article","created":{"date-parts":[[2017,4,21]],"date-time":"2017-04-21T22:16:44Z","timestamp":1492813004000},"page":"349-356","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":27,"title":["Phosphate imbalance in patients with heart failure"],"prefix":"10.1007","volume":"22","author":[{"given":"E. C.","family":"Christopoulou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T. D.","family":"Filippatos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Megapanou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. S.","family":"Elisaf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Liamis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,4,22]]},"reference":[{"key":"9615_CR1","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1007\/s10741-015-9482-y","volume":"20","author":"C Urso","year":"2015","unstructured":"Urso C, Brucculeri S, Caimi G (2015) Acid-base and electrolyte abnormalities in heart failure: pathophysiology and implications. Heart Fail Rev 20:493\u2013503","journal-title":"Heart Fail Rev"},{"key":"9615_CR2","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/S1388-9842(01)00234-3","volume":"4","author":"HJ Milionis","year":"2002","unstructured":"Milionis HJ, Alexandrides GE, Liberopoulos EN, Bairaktari ET, Goudevenos J, Elisaf MS (2002) Hypomagnesemia and concurrent acid-base and electrolyte abnormalities in patients with congestive heart failure. Eur J Heart Fail 4:167\u2013173","journal-title":"Eur J Heart Fail"},{"key":"9615_CR3","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1056\/NEJM198508153130711","volume":"313","author":"JP Knochel","year":"1985","unstructured":"Knochel JP (1985) The clinical status of hypophosphatemia: an update. N Engl J Med 313:447\u2013449","journal-title":"N Engl J Med"},{"key":"9615_CR4","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1016\/j.amjmed.2005.02.014","volume":"118","author":"A Gaasbeek","year":"2005","unstructured":"Gaasbeek A, Meinders AE (2005) Hypophosphatemia: an update on its etiology and treatment. Am J Med 118:1094\u20131101","journal-title":"Am J Med"},{"key":"9615_CR5","first-page":"402","volume":"448","author":"C Madjdpour","year":"2004","unstructured":"Madjdpour C, Bacic D, Kaissling B, Murer H, Biber J (2004) Segment-specific expression of sodium-phosphate cotransporters NaPi-IIa and -IIc and interacting proteins in mouse renal proximal tubules. Pflugers Arch 448:402\u2013410","journal-title":"Pflugers Arch"},{"key":"9615_CR6","doi-asserted-by":"crossref","first-page":"F691","DOI":"10.1152\/ajprenal.90623.2008","volume":"296","author":"R Villa-Bellosta","year":"2009","unstructured":"Villa-Bellosta R, Ravera S, Sorribas V et al (2009) The Na+\u2212Pi cotransporter PiT-2 (SLC20A2) is expressed in the apical membrane of rat renal proximal tubules and regulated by dietary Pi. Am J Physiol Renal Physiol 296:F691\u2013F699","journal-title":"Am J Physiol Renal Physiol"},{"key":"9615_CR7","doi-asserted-by":"crossref","first-page":"G501","DOI":"10.1152\/ajpgi.00168.2004","volume":"288","author":"A Stauber","year":"2005","unstructured":"Stauber A, Radanovic T, Stange G, Murer H, Wagner CA, Biber J (2005) Regulation of intestinal phosphate transport. II. Metabolic acidosis stimulates Na(+)-dependent phosphate absorption and expression of the Na(+)-P(i) cotransporter NaPi-IIb in small intestine. Am J Physiol Gastrointest Liver Physiol 288:G501\u2013G506","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"9615_CR8","doi-asserted-by":"crossref","first-page":"F395","DOI":"10.1152\/ajprenal.00100.2006","volume":"292","author":"H Segawa","year":"2007","unstructured":"Segawa H, Yamanaka S, Onitsuka A et al (2007) Parathyroid hormone-dependent endocytosis of renal type IIc Na-Pi cotransporter. Am J Physiol Renal Physiol 292:F395\u2013F403","journal-title":"Am J Physiol Renal Physiol"},{"key":"9615_CR9","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1007\/BF00584371","volume":"377","author":"KJ Ullrich","year":"1978","unstructured":"Ullrich KJ, Rumrich G, Kloss S (1978) Phosphate transport in the proximal convolution of the rat kidney. III. Effect of extracellular and intracellular pH. Pflugers Arch 377:33\u201342","journal-title":"Pflugers Arch"},{"key":"9615_CR10","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.2215\/CJN.09750913","volume":"10","author":"J Blaine","year":"2015","unstructured":"Blaine J, Chonchol M, Levi M (2015) Renal control of calcium, phosphate, and magnesium homeostasis. Clin J Am Soc Nephrol 10:1257\u20131272","journal-title":"Clin J Am Soc Nephrol"},{"key":"9615_CR11","first-page":"708","volume":"116","author":"II Costache","year":"2012","unstructured":"Costache II, Cimpoesu D, Petris O, Petris AO (2012) Electrolyte disturbances in patients with chronic heart failure\u2014clinical, evolutive and therapeutic implications. Rev Med Chir Soc Med Nat Iasi 116:708\u2013713","journal-title":"Rev Med Chir Soc Med Nat Iasi"},{"key":"9615_CR12","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/S1388-9842(01)00139-8","volume":"3","author":"A Jacobsson","year":"2001","unstructured":"Jacobsson A, Pihl-Lindgren E, Fridlund B (2001) Malnutrition in patients suffering from chronic heart failure; the nurse\u2019s care. Eur J Heart Fail 3:449\u2013456","journal-title":"Eur J Heart Fail"},{"key":"9615_CR13","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1016\/j.jacc.2007.07.016","volume":"50","author":"A Sandek","year":"2007","unstructured":"Sandek A, Bauditz J, Swidsinski A et al (2007) Altered intestinal function in patients with chronic heart failure. J Am Coll Cardiol 50:1561\u20131569","journal-title":"J Am Coll Cardiol"},{"key":"9615_CR14","doi-asserted-by":"crossref","first-page":"27","DOI":"10.3109\/08037059609062103","volume":"5","author":"SE Kjeldsen","year":"1996","unstructured":"Kjeldsen SE, Moan A, Petrin J, Weder AB, Julius S (1996) Effects of increased arterial epinephrine on insulin, glucose and phosphate. Blood Press 5:27\u201331","journal-title":"Blood Press"},{"key":"9615_CR15","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/j.ejcts.2004.03.004","volume":"26","author":"J Cohen","year":"2004","unstructured":"Cohen J, Kogan A, Sahar G, Lev S, Vidne B, Singer P (2004) Hypophosphatemia following open heart surgery: incidence and consequences. Eur J Cardiothorac Surg 26:306\u2013310","journal-title":"Eur J Cardiothorac Surg"},{"key":"9615_CR16","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/S1010-7940(01)01099-5","volume":"21","author":"D Paparella","year":"2002","unstructured":"Paparella D, Yau TM, Young E (2002) Cardiopulmonary bypass induced inflammation: pathophysiology and treatment. An update. Eur J Cardiothorac Surg 21:232\u2013244","journal-title":"Eur J Cardiothorac Surg"},{"key":"9615_CR17","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1093\/qjmed\/hcq039","volume":"103","author":"G Liamis","year":"2010","unstructured":"Liamis G, Milionis HJ, Elisaf M (2010) Medication-induced hypophosphatemia: a review. QJM 103:449\u2013459","journal-title":"QJM"},{"key":"9615_CR18","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1080\/AC.70.3.3080630","volume":"70","author":"FH Verbrugge","year":"2015","unstructured":"Verbrugge FH, Dupont M, Bertrand PB et al (2015) Determinants and impact of the natriuretic response to diuretic therapy in heart failure with reduced ejection fraction and volume overload. Acta Cardiol 70:265\u2013273","journal-title":"Acta Cardiol"},{"key":"9615_CR19","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1164\/rccm.200507-1035OC","volume":"173","author":"S Javaheri","year":"2006","unstructured":"Javaheri S (2006) Acetazolamide improves central sleep apnea in heart failure: a double-blind, prospective study. Am J Respir Crit Care Med 173:234\u2013237","journal-title":"Am J Respir Crit Care Med"},{"key":"9615_CR20","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1053\/j.ajkd.2012.10.028","volume":"61","author":"AJ Peixoto","year":"2013","unstructured":"Peixoto AJ, Alpern RJ (2013) Treatment of severe metabolic alkalosis in a patient with congestive heart failure. Am J Kidney Dis 61:822\u2013827","journal-title":"Am J Kidney Dis"},{"key":"9615_CR21","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/j.cardfail.2014.01.007","volume":"20","author":"A Apostolo","year":"2014","unstructured":"Apostolo A, Agostoni P, Contini M, Antonioli L, Swenson ER (2014) Acetazolamide and inhaled carbon dioxide reduce periodic breathing during exercise in patients with chronic heart failure. J Card Fail 20:278\u2013288","journal-title":"J Card Fail"},{"key":"9615_CR22","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1016\/j.bmc.2008.12.023","volume":"17","author":"C Temperini","year":"2009","unstructured":"Temperini C, Cecchi A, Scozzafava A, Supuran CT (2009) Carbonic anhydrase inhibitors. Comparison of chlorthalidone, indapamide, trichloromethiazide, and furosemide X-ray crystal structures in adducts with isozyme II, when several water molecules make the difference. Bioorg Med Chem 17:1214\u20131221","journal-title":"Bioorg Med Chem"},{"key":"9615_CR23","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1016\/S0889-8529(05)70152-3","volume":"29","author":"LA DiMeglio","year":"2000","unstructured":"DiMeglio LA, White KE, Econs MJ (2000) Disorders of phosphate metabolism. Endocrinol Metab Clin N Am 29:591\u2013609","journal-title":"Endocrinol Metab Clin N Am"},{"key":"9615_CR24","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1152\/ajplegacy.1967.212.6.1347","volume":"212","author":"HE Ginn","year":"1967","unstructured":"Ginn HE, Shanbour LL (1967) Phosphaturia in magnesium-deficient rats. Am J Phys 212:1347\u20131350","journal-title":"Am J Phys"},{"key":"9615_CR25","first-page":"167","volume":"85","author":"V Fainardi","year":"2014","unstructured":"Fainardi V, Cabassi A, Carano N et al (2014) Severe hypokalemia and hypophosphatemia presenting with carpopedal spasm associated with rhabdomyolysis. Acta Biomed 85:167\u2013170","journal-title":"Acta Biomed"},{"key":"9615_CR26","doi-asserted-by":"crossref","first-page":"2649","DOI":"10.1681\/ASN.2007070792","volume":"18","author":"CL Huang","year":"2007","unstructured":"Huang CL, Kuo E (2007) Mechanism of hypokalemia in magnesium deficiency. J Am Soc Nephrol 18:2649\u20132652","journal-title":"J Am Soc Nephrol"},{"key":"9615_CR27","doi-asserted-by":"crossref","first-page":"1572","DOI":"10.1111\/j.1742-1241.2008.01860.x","volume":"62","author":"G Liamis","year":"2008","unstructured":"Liamis G, Milionis H, Elisaf M (2008) Blood pressure drug therapy and electrolyte disturbances. Int J Clin Pract 62:1572\u20131580","journal-title":"Int J Clin Pract"},{"key":"9615_CR28","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1016\/j.kint.2015.11.018","volume":"89","author":"RH Sterns","year":"2016","unstructured":"Sterns RH, Grieff M, Bernstein PL (2016) Treatment of hyperkalemia: something old, something new. Kidney Int 89:546\u2013554","journal-title":"Kidney Int"},{"key":"9615_CR29","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1016\/j.cardfail.2008.04.001","volume":"14","author":"A Cohen-Solal","year":"2008","unstructured":"Cohen-Solal A, Beauvais F, Logeart D (2008) Heart failure and diabetes mellitus: epidemiology and management of an alarming association. J Card Fail 14:615\u2013625","journal-title":"J Card Fail"},{"key":"9615_CR30","doi-asserted-by":"crossref","first-page":"488","DOI":"10.12998\/wjcc.v2.i10.488","volume":"2","author":"G Liamis","year":"2014","unstructured":"Liamis G, Liberopoulos E, Barkas F, Elisaf M (2014) Diabetes mellitus and electrolyte disorders. World J Clin Cases 2:488\u2013496","journal-title":"World J Clin Cases"},{"key":"9615_CR31","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1038\/nrd3180","volume":"9","author":"EC Chao","year":"2010","unstructured":"Chao EC, Henry RR (2010) SGLT2 inhibition\u2014a novel strategy for diabetes treatment. Nat Rev Drug Discov 9:551\u2013559","journal-title":"Nat Rev Drug Discov"},{"key":"9615_CR32","doi-asserted-by":"crossref","first-page":"1759","DOI":"10.1185\/03007995.2014.919907","volume":"30","author":"MR Weir","year":"2014","unstructured":"Weir MR, Kline I, Xie J, Edwards R, Usiskin K (2014) Effect of canagliflozin on serum electrolytes in patients with type 2 diabetes in relation to estimated glomerular filtration rate (eGFR). Curr Med Res Opin 30:1759\u20131768","journal-title":"Curr Med Res Opin"},{"key":"9615_CR33","first-page":"274","volume":"20","author":"M Elisaf","year":"1994","unstructured":"Elisaf M, Merkouropoulos M, Tsianos EV, Siamopoulos KC (1994) Acid-base and electrolyte abnormalities in alcoholic patients. Miner Electrolyte Metab 20:274\u2013281","journal-title":"Miner Electrolyte Metab"},{"key":"9615_CR34","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1111\/j.1742-1241.1997.tb11534.x","volume":"51","author":"MS Elisaf","year":"1997","unstructured":"Elisaf MS, Siamopoulos KC (1997) Mechanisms of hypophosphataemia in alcoholic patients. Int J Clin Pract 51:501\u2013503","journal-title":"Int J Clin Pract"},{"key":"9615_CR35","doi-asserted-by":"crossref","first-page":"1927","DOI":"10.1056\/NEJM199312233292605","volume":"329","author":"S De Marchi","year":"1993","unstructured":"De Marchi S, Cecchin E, Basile A, Bertotti A, Nardini R, Bartoli E (1993) Renal tubular dysfunction in chronic alcohol abuse\u2014effects of abstinence. N Engl J Med 329:1927\u20131934","journal-title":"N Engl J Med"},{"key":"9615_CR36","first-page":"185","volume":"3","author":"M Elisaf","year":"2015","unstructured":"Elisaf M, Kalaitzidis R (2015) Metabolic abnormalities in alcoholic patients: focus on acid base and electrolyte disorders. J Alcohol Drug Depend 3:185","journal-title":"J Alcohol Drug Depend"},{"key":"9615_CR37","doi-asserted-by":"crossref","first-page":"3378","DOI":"10.1096\/fj.201600473R","volume":"30","author":"DH Pesta","year":"2016","unstructured":"Pesta DH, Tsirigotis DN, Befroy DE et al (2016) Hypophosphatemia promotes lower rates of muscle ATP synthesis. FASEB J 30:3378\u20133387","journal-title":"FASEB J"},{"key":"9615_CR38","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1111\/j.1530-0277.1987.tb01274.x","volume":"11","author":"N Brautbar","year":"1987","unstructured":"Brautbar N, Altura BM (1987) Hypophosphatemia and hypomagnesemia result in cardiovascular dysfunction: theoretical basis for alcohol-induced cellular injury. Alcohol Clin Exp Res 11:118\u2013126","journal-title":"Alcohol Clin Exp Res"},{"key":"9615_CR39","doi-asserted-by":"crossref","first-page":"2190","DOI":"10.1161\/01.CIR.96.7.2190","volume":"96","author":"S Neubauer","year":"1997","unstructured":"Neubauer S, Horn M, Cramer M et al (1997) Myocardial phosphocreatine-to-ATP ratio is a predictor of mortality in patients with dilated cardiomyopathy. Circulation 96:2190\u20132196","journal-title":"Circulation"},{"key":"9615_CR40","doi-asserted-by":"crossref","first-page":"1810","DOI":"10.1161\/01.CIR.86.6.1810","volume":"86","author":"S Neubauer","year":"1992","unstructured":"Neubauer S, Krahe T, Schindler R et al (1992) 31P magnetic resonance spectroscopy in dilated cardiomyopathy and coronary artery disease. Altered cardiac high-energy phosphate metabolism in heart failure. Circulation 86:1810\u20131818","journal-title":"Circulation"},{"key":"9615_CR41","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1056\/NEJMra063052","volume":"356","author":"S Neubauer","year":"2007","unstructured":"Neubauer S (2007) The failing heart\u2014an engine out of fuel. N Engl J Med 356:1140\u20131151","journal-title":"N Engl J Med"},{"key":"9615_CR42","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1016\/S0735-1097(02)02160-5","volume":"40","author":"M Beer","year":"2002","unstructured":"Beer M, Seyfarth T, Sandstede J et al (2002) Absolute concentrations of high-energy phosphate metabolites in normal, hypertrophied, and failing human myocardium measured noninvasively with (31)P-SLOOP magnetic resonance spectroscopy. J Am Coll Cardiol 40:1267\u20131274","journal-title":"J Am Coll Cardiol"},{"key":"9615_CR43","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1136\/heartjnl-2012-302546","volume":"100","author":"MB Bizino","year":"2014","unstructured":"Bizino MB, Hammer S, Lamb HJ (2014) Metabolic imaging of the human heart: clinical application of magnetic resonance spectroscopy. Heart 100:881\u2013890","journal-title":"Heart"},{"key":"9615_CR44","doi-asserted-by":"crossref","first-page":"e107","DOI":"10.1371\/journal.pcbi.0020107","volume":"2","author":"DA Beard","year":"2006","unstructured":"Beard DA (2006) Modeling of oxygen transport and cellular energetics explains observations on in vivo cardiac energy metabolism. PLoS Comput Biol 2:e107","journal-title":"PLoS Comput Biol"},{"key":"9615_CR45","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1056\/NEJM197710272971702","volume":"297","author":"LR O\u2019Connor","year":"1977","unstructured":"O\u2019Connor LR, Wheeler WS, Bethune JE (1977) Effect of hypophosphatemia on myocardial performance in man. N Engl J Med 297:901\u2013903","journal-title":"N Engl J Med"},{"key":"9615_CR46","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1002\/clc.4960190905","volume":"19","author":"S Ferraro","year":"1996","unstructured":"Ferraro S, Codella C, Palumbo F et al (1996) Hemodynamic effects of creatine phosphate in patients with congestive heart failure: a double-blind comparison trial versus placebo. Clin Cardiol 19:699\u2013703","journal-title":"Clin Cardiol"},{"key":"9615_CR47","doi-asserted-by":"crossref","first-page":"460","DOI":"10.3177\/jnsv.61.460","volume":"61","author":"SO Keskek","year":"2015","unstructured":"Keskek SO, Sagliker Y, Kirim S, Icen YK, Yildirim A (2015) Low serum phosphorus level in Massry\u2019s phosphate depletion syndrome may be one of the causes of acute heart failure. J Nutr Sci Vitaminol (Tokyo) 61:460\u2013464","journal-title":"J Nutr Sci Vitaminol (Tokyo)"},{"key":"9615_CR48","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1097\/00000441-198803000-00004","volume":"295","author":"SV Davis","year":"1988","unstructured":"Davis SV, Olichwier KK, Chakko SC (1988) Reversible depression of myocardial performance in hypophosphatemia. Am J Med Sci 295:183\u2013187","journal-title":"Am J Med Sci"},{"key":"9615_CR49","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1053\/ajem.2002.33950","volume":"20","author":"I Claudius","year":"2002","unstructured":"Claudius I, Sachs C, Shamji T (2002) Hypophosphatemia-induced heart failure. Am J Emerg Med 20:369\u2013370","journal-title":"Am J Emerg Med"},{"key":"9615_CR50","doi-asserted-by":"crossref","first-page":"19","DOI":"10.5049\/EBP.2014.12.1.19","volume":"12","author":"A Schwartz","year":"2014","unstructured":"Schwartz A, Brotfain E, Koyfman L et al (2014) Association between hypophosphatemia and cardiac arrhythmias in the early stage of sepsis: could phosphorus replacement treatment reduce the incidence of arrhythmias? Electrolyte Blood Press 12:19\u201325","journal-title":"Electrolyte Blood Press"},{"key":"9615_CR51","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1097\/00007611-199401000-00014","volume":"87","author":"A Ognibene","year":"1994","unstructured":"Ognibene A, Ciniglio R, Greifenstein A et al (1994) Ventricular tachycardia in acute myocardial infarction: the role of hypophosphatemia. South Med J 87:65\u201369","journal-title":"South Med J"},{"key":"9615_CR52","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1007\/s40620-014-0075-y","volume":"28","author":"RM Cubbon","year":"2015","unstructured":"Cubbon RM, Thomas CH, Drozd M et al (2015) Calcium, phosphate and calcium phosphate product are markers of outcome in patients with chronic heart failure. J Nephrol 28:209\u2013215","journal-title":"J Nephrol"},{"key":"9615_CR53","doi-asserted-by":"crossref","first-page":"247","DOI":"10.3389\/fphys.2013.00247","volume":"4","author":"N Itoh","year":"2013","unstructured":"Itoh N, Ohta H (2013) Pathophysiological roles of FGF signaling in the heart. Front Physiol 4:247","journal-title":"Front Physiol"},{"key":"9615_CR54","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/j.numecd.2016.06.007","volume":"26","author":"A Zittermann","year":"2016","unstructured":"Zittermann A, Ernst JB (2016) Calciotropic and phosphaturic hormones in heart failure. Nutr Metab Cardiovasc Dis 26:971\u2013979","journal-title":"Nutr Metab Cardiovasc Dis"},{"key":"9615_CR55","first-page":"H1739","volume":"263","author":"KD Schluter","year":"1992","unstructured":"Schluter KD, Piper HM (1992) Trophic effects of catecholamines and parathyroid hormone on adult ventricular cardiomyocytes. Am J Phys 263:H1739\u2013H1746","journal-title":"Am J Phys"},{"key":"9615_CR56","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1161\/CIRCHEARTFAILURE.114.001272","volume":"7","author":"SG Wannamethee","year":"2014","unstructured":"Wannamethee SG, Welsh P, Papacosta O, Lennon L, Whincup PH, Sattar N (2014) Elevated parathyroid hormone, but not vitamin D deficiency, is associated with increased risk of heart failure in older men with and without cardiovascular disease. Circ Heart Fail 7:732\u2013739","journal-title":"Circ Heart Fail"},{"key":"9615_CR57","doi-asserted-by":"crossref","first-page":"e4810","DOI":"10.1097\/MD.0000000000004810","volume":"95","author":"F Meng","year":"2016","unstructured":"Meng F, Wang W, Ma J, Lin B (2016) Parathyroid hormone and risk of heart failure in the general population: a meta-analysis of prospective studies. Medicine (Baltimore) 95:e4810","journal-title":"Medicine (Baltimore)"},{"key":"9615_CR58","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/j.cca.2014.03.029","volume":"433","author":"D Gruson","year":"2014","unstructured":"Gruson D, Buglioni A, Burnett JC Jr (2014) PTH: potential role in management of heart failure. Clin Chim Acta 433:290\u2013296","journal-title":"Clin Chim Acta"},{"key":"9615_CR59","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1007\/s007740050101","volume":"18","author":"T Fujita","year":"2000","unstructured":"Fujita T, Palmieri GM (2000) Calcium paradox disease: calcium deficiency prompting secondary hyperparathyroidism and cellular calcium overload. J Bone Miner Metab 18:109\u2013125","journal-title":"J Bone Miner Metab"},{"key":"9615_CR60","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.metabol.2013.08.016","volume":"63","author":"A Tomaschitz","year":"2014","unstructured":"Tomaschitz A, Ritz E, Pieske B et al (2014) Aldosterone and parathyroid hormone interactions as mediators of metabolic and cardiovascular disease. Metabolism 63:20\u201331","journal-title":"Metabolism"},{"key":"9615_CR61","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1093\/cvr\/cvs092","volume":"94","author":"A Tomaschitz","year":"2012","unstructured":"Tomaschitz A, Ritz E, Pieske B et al (2012) Aldosterone and parathyroid hormone: a precarious couple for cardiovascular disease. Cardiovasc Res 94:10\u201319","journal-title":"Cardiovasc Res"},{"key":"9615_CR62","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1161\/01.CIR.0000155621.10213.06","volume":"111","author":"VS Chhokar","year":"2005","unstructured":"Chhokar VS, Sun Y, Bhattacharya SK et al (2005) Hyperparathyroidism and the calcium paradox of aldosteronism. Circulation 111:871\u2013878","journal-title":"Circulation"},{"key":"9615_CR63","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1007\/s10557-012-6378-0","volume":"27","author":"MR Rutledge","year":"2013","unstructured":"Rutledge MR, Farah V, Adeboye AA, Seawell MR, Bhattacharya SK, Weber KT (2013) Parathyroid hormone, a crucial mediator of pathologic cardiac remodeling in aldosteronism. Cardiovasc Drugs Ther 27:161\u2013170","journal-title":"Cardiovasc Drugs Ther"},{"key":"9615_CR64","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1159\/000346784","volume":"180","author":"MS Razzaque","year":"2013","unstructured":"Razzaque MS (2013) Phosphate toxicity and vascular mineralization. Contrib Nephrol 180:74\u201385","journal-title":"Contrib Nephrol"},{"key":"9615_CR65","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1053\/j.ackd.2006.10.006","volume":"14","author":"P Raggi","year":"2007","unstructured":"Raggi P, Bellasi A (2007) Clinical assessment of vascular calcification. Adv Chronic Kidney Dis 14:37\u201343","journal-title":"Adv Chronic Kidney Dis"},{"key":"9615_CR66","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1161\/ATVBAHA.106.132266","volume":"27","author":"R Villa-Bellosta","year":"2007","unstructured":"Villa-Bellosta R, Bogaert YE, Levi M, Sorribas V (2007) Characterization of phosphate transport in rat vascular smooth muscle cells: implications for vascular calcification. Arterioscler Thromb Vasc Biol 27:1030\u20131036","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"9615_CR67","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1161\/01.RES.0000216409.20863.e7","volume":"98","author":"X Li","year":"2006","unstructured":"Li X, Yang HY, Giachelli CM (2006) Role of the sodium-dependent phosphate cotransporter, Pit-1, in vascular smooth muscle cell calcification. Circ Res 98:905\u2013912","journal-title":"Circ Res"},{"key":"9615_CR68","doi-asserted-by":"crossref","first-page":"2625","DOI":"10.1161\/ATVBAHA.113.302249","volume":"33","author":"MH Crouthamel","year":"2013","unstructured":"Crouthamel MH, Lau WL, Leaf EM et al (2013) Sodium-dependent phosphate cotransporters and phosphate-induced calcification of vascular smooth muscle cells: redundant roles for PiT-1 and PiT-2. Arterioscler Thromb Vasc Biol 33:2625\u20132632","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"9615_CR69","first-page":"387","volume":"23","author":"S Rathan","year":"2014","unstructured":"Rathan S, Yoganathan AP, O\u2019Neill CW (2014) The role of inorganic pyrophosphate in aortic valve calcification. J Heart Valve Dis 23:387\u2013394","journal-title":"J Heart Valve Dis"},{"key":"9615_CR70","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1681\/ASN.2008020141","volume":"20","author":"RN Foley","year":"2009","unstructured":"Foley RN, Collins AJ, Herzog CA, Ishani A, Kalra PA (2009) Serum phosphorus levels associate with coronary atherosclerosis in young adults. J Am Soc Nephrol 20:397\u2013404","journal-title":"J Am Soc Nephrol"},{"key":"9615_CR71","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1681\/ASN.2008040349","volume":"20","author":"KL Adeney","year":"2009","unstructured":"Adeney KL, Siscovick DS, Ix JH et al (2009) Association of serum phosphate with vascular and valvular calcification in moderate CKD. J Am Soc Nephrol 20:381\u2013387","journal-title":"J Am Soc Nephrol"},{"key":"9615_CR72","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.joa.2014.06.006","volume":"31","author":"Y Kamiyama","year":"2015","unstructured":"Kamiyama Y, Suzuki H, Yamada S, Kaneshiro T, Takeishi Y (2015) Serum phosphate levels reflect responses to cardiac resynchronization therapy in chronic heart failure patients. J Arrhythm 31:38\u201342","journal-title":"J Arrhythm"},{"key":"9615_CR73","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1053\/j.ajkd.2012.03.024","volume":"60","author":"AJ Felsenfeld","year":"2012","unstructured":"Felsenfeld AJ, Levine BS (2012) Approach to treatment of hypophosphatemia. Am J Kidney Dis 60:655\u2013661","journal-title":"Am J Kidney Dis"},{"key":"9615_CR74","doi-asserted-by":"crossref","first-page":"2589","DOI":"10.1517\/14656566.2015.1092521","volume":"16","author":"G Spasovski","year":"2015","unstructured":"Spasovski G (2015) Advances in pharmacotherapy for hyperphosphatemia in renal disease. Expert Opin Pharmacother 16:2589\u20132599","journal-title":"Expert Opin Pharmacother"}],"container-title":["Heart Failure Reviews"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10741-017-9615-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10741-017-9615-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10741-017-9615-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,23]],"date-time":"2023-08-23T03:02:25Z","timestamp":1692759745000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10741-017-9615-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,4,22]]},"references-count":74,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2017,5]]}},"alternative-id":["9615"],"URL":"https:\/\/doi.org\/10.1007\/s10741-017-9615-6","relation":{},"ISSN":["1382-4147","1573-7322"],"issn-type":[{"value":"1382-4147","type":"print"},{"value":"1573-7322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,4,22]]}}}